Another study [37] used a panel of HCT116 cell lines with differential β-catenin mutation status and suggested that β-catenin activation induces EMT progression by modifying E-cadherin-dependent cell–cell junctions, and thereby contributes to CRC aggressiveness. This evidence concerns the gene CDH1 and colorectal carcinoma.